End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.98 CNY | +0.64% |
|
+12.50% | +2.33% |
05-28 | China Grants Clinical Trial Approval for Zhejiang Medicine's Antibacterial Injection | MT |
04-25 | Zhejiang Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.33% | 1.43B | |
+55.72% | 819B | |
-6.81% | 351B | |
+16.23% | 329B | |
+10.41% | 298B | |
+16.57% | 242B | |
+2.04% | 225B | |
+13.31% | 217B | |
+8.54% | 168B | |
-2.88% | 158B |
- Stock Market
- Equities
- 600216 Stock
- News Zhejiang Medicine Co., Ltd.
- Zhejiang Medicine Wins Nod to Trial Anti-Tumor Drug